Recent Quarter Total Invested
$423,638
Recent Quarter Institutional Ownership Percentage
10.88%
Total Invested of Last Quarter
$81,774
Ownership Percentage of Last Quarter
3.53%
Virax Biolabs Group Limited Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SQUAREPOINT OPS LLC | 11/14/2024 | 40,620 | $78,803 | 100.00% | 2.02% |
| HEADLANDS TECHNOLOGIES LLC | 11/12/2024 | 185 | $359 | 311.11% | 0.01% |
| HRT FINANCIAL LP | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Virax Biolabs Group Limitedinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of VRAX shares?
During the previous two years, 5 institutional investors and hedge funds held shares of Virax Biolabs Group Limited. The most heavily invested institutionals were:
Squarepoint Ops LLC: 40,620
Headlands Technologies LLC: 185
Qube Research & Technologies Ltd: 0
Virtu Financial LLC: 0
HRT FINANCIAL LP: 0
-
What percentage of Virax Biolabs Group Limited stock is owned by institutional investors?
10.88% of Virax Biolabs Group Limited stock is owned by institutional investors.
-
How much institutional buying is happening at VRAX ?
Institutional investors have bought a total of 40,805 shares in the last 24 months. This purchase volume represents approximately $82,018 in transactions.